PPARGC1A and Hepatic steatosis: Moreover, NT-PGC-1α−/− female mice were protected from HFD-induced hepatic steatosis as evidenced by a decrease in weight, lipid droplet accumulation, and TG content in the liver (Fig. 4A–C).